Medical Science Liaison

Core responsibilities

Scientific exchange with HCPs and experts:

• Engage in peertopeer compliant scientific discussions with KOLs and HCPs (e.g. allergists ENT pulmonologists pediatricians GPs) on disease state clinical evidence guidelines and appropriate use of ALK therapies.
• Deliver nonpromotional scientific presentations (1:1 and group) at meetings clinical sessions and educational events.
• Support scientific advisory boards and educational initiatives to inform clinical evidence needs and advance best practice in patient care.
• Systematically capture synthesize and share field insights (HCPs reimbursement stakeholders hospital committees)
• Use approved materials; document field interactions and insights in approved systems (Veeva).
• Monitor and communicate scientific developments competitor clinical evidence and guideline updates relevant to ALKs therapeutic areas.

Market access stakeholder engagement (nonpromotional):

• Map and cultivate scientific relationships with reimbursement and access stakeholders including INAMI/RIZIV mutualities/sickness funds and hospital formulary/P&T committees; engage competent authorities (e.g. AFMPS) for scientific exchange as appropriate in line with Medical governance and local codes.
• Communicate unbiased evidencebased clinical value messages derived from the Global/Local Value Dossier tailored to the needs of payer and access stakeholders.
• Respond to scientific queries from reimbursement stakeholders and coordinate timely compliant followup with internal Medical and Market Access colleagues.

Value dossier and scientific support:

• Contribute to the local adaptation of the Global Value Dossier for Belgium: ensure the clinical narrative comparators endpoints epidemiology and care pathways reflect local practice and expectations.
• Curate review and align local clinical literature and guideline updates to support value messaging and access materials under Medical governance.
• Support development of scientific briefing documents and FAQs for use in compliant engagements with access stakeholders; ensure consistency and accuracy across materials.

Education: Advanced degree in life sciences (PhD MD PharmD MSc) required.

Experience: Prior MSL/Medical Affairs experience in pharma/biotech strongly preferred; experience engaging with reimbursement stakeholders in Belgium is a plus.

Scientific/clinical: Strong ability to interpret and communicate clinical evidence; familiarity with immunology/allergy/respiratory is advantageous.

Communication: Excellent scientific communication and presentation skills; ability to translate complex clinical evidence into clear balanced stakeholderappropriate scientific messages.

Project management: Proven ability to manage crossfunctional projects with multiple stakeholders and timelines.

Languages: Fluency in French and English required; proficiency in Dutch preferred (role is Walloniafocused but national stakeholder interactions often require Dutch/English).

Other: Valid drivers license; willingness to travel 6070% within Wallonia and to Brussels for national engagements.

Location: Belgium (field-based Wallonia; regular travel to Brussels for national stakeholders)